-
Estimating Costs Associated with Adverse Events in Patients with Advanced Lung Cancer
19 Oct 2024 05:20 GMT
… with advanced lung cancer between 2011 and 2019. Lung cancer diagnosis … small cell lung cancer, squamous non-small cell lung cancer (NSCLC), … , use of oral vinorelbine was not considered in … advanced non-small-cell lung cancer. Clin Lung Cancer. 2018;19(5 …
-
Lung Cancer Therapeutics Market to Deliver Greater Revenues during the Forecast Period 2024 – 2032
28 Jun 2024 12:03 GMT
… medication access.
Lung Cancer Therapeutics Top Companies … sales milestones.
Lung Cancer Therapeutics Market Segment …
Cisplatin
Taxol
Navelbine
Camptosar
Alimta
Distribution … Small Cell Lung Cancer (NSCLC)
Small Cell Lung Cancer (SCLC …
-
Combined Dacomitinib and Selpercatinib Treatment for a Patient with EGFR-Mutant Non-Small Cell Lung Cancer and Acquired CCDC6-RET Fusion
18 Jun 2024 10:10 GMT
… left parietal bone. A lung tumor biopsy showed a poorly … gene.
Second-line oral vinorelbine was initiated, but refractory … EGFR therapy in EGFR-Mutated Lung Cancers. J Thorac Oncol. 2019 … non-small-cell lung cancer: a brief report. Lung Cancer. 2021;152:66 …
-
Research Progress of Baihe Gujin Decoction in the Treatment of Lung Cancer
23 Apr 2024 17:30 GMT
… cell lung cancer (NSCLC) and small cell lung cancer ( … Lung Cancers
Clinical Study of Baihe Gujin Decoction in the Treatment of Lung Cancer … lung cancer patients. For instance, Baihe Gujin decoction with vinorelbine … lung cancer. In the study on 84 lung cancer …
-
Cost-Effectiveness of First-Line Atezolizumab versus Chemotherapy in Non-Small-Cell Lung Cancer Patients Ineligible for Platinum-Containing Regimens
11 Apr 2024 16:52 GMT
… for non-small-cell lung cancer (NSCLC) patients ineligible … 7,8 of all lung cancers cases, with nearly … proportion of gemcitabine and vinorelbine usage. Consequently, we … small-cell lung cancer: a cost-effectiveness analysis. Translational Lung Cancer Res. …
-
Two Datopotamab Deruxtecan Applications Validated in the EU for Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer or HR Positive, HER2 Negative Breast Cancer
04 Mar 2024 10:29 GMT
… nonsquamous non-small cell lung cancer (NSCLC) who … chemotherapy (eribulin, capecitabine, vinorelbine or gemcitabine) in patients … Small Cell Lung Cancer
Nearly 500,000 lung cancer cases were … References:
1 Cancer.net. Lung Cancer – Non-Small Cell: Statistics …
-
Global Lung Cancer Drugs Market Forecast 2024-2033 – Market Size, Drivers, Trends, And Competitors
27 Dec 2023 16:45 GMT
… .
Lung Cancer Drugs Market Segments
• By Drugs: Gemzar, Paraplatin, Taxotere, Navelbine, … lung cancer (SCLC) and non-small cell lung cancer (NSCLC). Small cell lung cancer … is a type of lung cancer that …
-
Clinical Trials for Oral, Inhaled and Intravenous Drug Delivery System for Lung Cancer and Emerging Nanomedicine-Based Approaches
21 Dec 2023 04:45 GMT
… lung cancers. The two broad histological subtypes of lung cancer are small cell lung cancer … targeted delivery to lung tumors is a promising … 47;d) of oral vinorelbine (Navelbine®oral, NVBo) is … -small-cell lung cancer with daily oral vinorelbine–a Phase …
-
Global Lung Cancer Drugs Market Forecast 2023-2032 – Market Size, Drivers, Trends, And Competitors
28 Sep 2023 16:30 GMT
… lung cancer (SCLC), Non-small cell lung cancer … Navelbine, Avastin, Tarceva, Iressa, Other Drugs
• By Geography: The global lung cancer … treat lung cancer. Lung cancer … lung cancer (SCLC) and non-small cell lung cancer (NSCLC).
Read More On The Lung Cancer …
-
Atezolizumab monotherapy bests single-agent chemotherapy among patients with advanced non-small-cell lung cancer
05 Sep 2023 16:23 GMT
… or metastatic non-small-cell lung cancer (NSCLC), pivotal first- … or single-agent chemotherapy (vinorelbine [oral or intravenous] or … with non-small-cell lung cancer ineligible for treatment with … , advanced, non-small-cell lung cancer, The Lancet, Prof Siow …
About
© 1995-2024